Drug improves measures of genetic disease that affects liver, spleen

17 febrero 2015

Among previously untreated adults with Gaucher disease type 1, a genetic disease in which there is improper metabolism due to a defect in an enzyme, treatment with the drug eliglustat resulted in significant improvements in liver and spleen size hemoglobin level, and platelet count, according to a new study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/NSVyf4BHvEM/150217114005.htm

Volver